Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.100
0.00 (0.00%)
At close: Dec 20, 2024, 4:00 PM
4.200
+0.100 (2.44%)
After-hours: Dec 20, 2024, 7:58 PM EST
Cingulate Market Cap
Cingulate has a market cap or net worth of $13.17 million as of December 20, 2024. Its market cap has increased by 276.83% in one year.
Market Cap
13.17M
Enterprise Value
3.36M
1-Year Change
276.83%
Ranking
Category
Stock Price
$4.10
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $13.17M, a decrease of -79.51%. That is a compound annual growth rate of -40.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 13.17M | 83.73% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovative Eyewear | 13.92M |
| ImmunoPrecise Antibodies | 13.42M |
| Impact BioMedical | 13.34M |
| Lifeward | 13.21M |
| Kazia Therapeutics | 13.15M |
| Brainstorm Cell Therapeutics | 13.00M |
| Eterna Therapeutics | 12.85M |
| Aspira Women's Health | 12.83M |